Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants

dmLT Adjuvant Enhances Cytokine Responses to T Cell Stimuli, Whole Cell Vaccine Antigens and Lipopolysaccharide in Both Adults and Infants

(2021) Marjahan Akhtar et al.   Frontiers in Immunology

A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children

(2019) Rubhana Raqib et al.   Human Vaccines & Immunotherapeutics

Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh

(2019) Aklima Akter et al.   PLoS Neglected Tropical Diseases

Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial

(2019) Firdausi Qadri et al.   LANCET INFECTIOUS DISEASES

Current and future cholera vaccines

(2019) Hanif Shaikh et al.   VACCINE

Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development

(2018) Subhra Chakraborty et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial

(2018) Firdausi Qadri et al.   LANCET INFECTIOUS DISEASES

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers

(2018) Kamrul Islam et al.   PLoS Neglected Tropical Diseases

Oral cholera vaccines and their impact on the global burden of disease

(2018) Thomas F. Wierzba   Human Vaccines & Immunotherapeutics

Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses

(2018) Marjahan Akhtar et al.   VACCINE

Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country

(2017) Marjahan Akhtar et al.   VACCINE

Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine

(2016) Anna Lundgren et al.   VACCINE

Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study

(2014) Anna Lundgren et al.   VACCINE

Shift in Phenotypic Characteristics of Enterotoxigenic Escherichia coli (ETEC) Isolated from Diarrheal Patients in Bangladesh

(2014) Yasmin Ara Begum et al.   PLoS Neglected Tropical Diseases

Immune Responses to the O-Specific Polysaccharide Antigen in Children Who Received a Killed Oral Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

(2013) Daniel T. Leung et al.   Clinical and Vaccine Immunology

Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: A tool for assessing immunological memory

(2013) Susannah Leach et al.   VACCINE

Recent progress toward an enterotoxigenicEscherichia colivaccine

(2012) Ann-Mari Svennerholm et al.   Expert Review of Vaccines

A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression

(2011) S.D. Isidean et al.   VACCINE